Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Melanoma Adjuvant/Neoadjuvant

Caroline Robert

MD, PhD

🏢Gustave Roussy🌐France

Head of Dermatology Unit

115
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Caroline Robert is a global melanoma authority who led the KEYNOTE-006 trial establishing pembrolizumab as first-line therapy for advanced melanoma and contributed to adjuvant pembrolizumab development. Her long-term follow-up studies have documented unprecedented durable survival outcomes with immunotherapy. She is one of the most influential melanoma researchers worldwide.

Share:

🧪Research Fields 研究领域

Melanoma
Checkpoint immunotherapy
Adjuvant pembrolizumab
Long-term survival
Dermatologic oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Caroline Robert 的研究动态

Follow Caroline Robert's research updates

留下邮箱,当我们发布与 Caroline Robert(Gustave Roussy)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment